My thoughts on the 100 million shares. Here is

My thoughts on the 100 million shares.

Here is something more positive, more constructive for board conversation. Bear with me.

Dalton has 100 million shares less at the end of the 3rd Q than the 2nd Q. So isn't anyone intrigued by that, I sure am. I have 3 scenarios, all 3 are my OPINION. From 3,2,1.

#3. Dalton gave the shares to family. If so, he did it the last day of September and they received them October 1st or 2nd. Doc and Blickstein are the only shareholders in the financials 3rd Q. If given to family 3rd Q, they would be listed. I don't think this happened because Doc can wait until a few days before the launch, give his PERSONAL shares to family at a low value, merge and launch. We did not launch yet, so I doubt he gave them to family.

#2. Dalton gave them to Ellis, Farnworth, Herron and Grant. Same as above, because they are not listed on the 3rd Q. But he COULD have given it to them. I doubt it. Because, Grant is on the Board of Directors and few BOD members own stock in the company they sit on. This is because of the appearance of a conflict of interest. Also, why would Dalton give his personal stock to company employees? They will get treasury issued stock as bonuses, coming from Univec, not Dalton. Also 100 million shares is one huge bonus, lol. So, I really doubt this was the use of the 100 million shares.

#1. This is where it gets very interesting, IMO. Background first for those newer and those who forgot. Anyone that has been here more than four years knows Dalton and Bio Remedies go way, way back. Dalton has been on the Maryland Bio Park Board for a long time. BioRemedies rents space there. I think there was even a picture of Dalton and the BioRem CEO at a party together. Four or Five years ago, many of us here thought BioRemedies was helping Dalton develop his pharmaceutical grade remedies. Also, there was the Catalent Corp. "dot". They help companies develop product and take it to the FDA for approval. Then there was Paragon and other FDA approved packer "dots" as well as grower "dots". To many of us, Doc was developing cannabis based pharmaceutical grade remedies. Companies can develop their products in total secrecy (competition). Dalton started playing it closer to his vest, but his recent Linkedin Bio changes tells us he is still in cannabis and the OTC Markets profile states "Provider of specialty pharmaceuticals and mental health services" and the only pharmaceuticals that Doc has talked about changing the "industry" with, are cannabis based. Also remember during Covid-19, BioRemedies put out that PR with the patch? IMO, Dalton is still in the cannabis business and linked to BioRemedies. Also the "time line" seems to fit, 3rd Q and the 51% article.

Now, the background done, IMO, the interesting part. Referencing, Smach's post 79292. I absolutely believe Dalton bought 51% of BioRemedies. The 100 million shares less owned and the article timing fits and the above background. Dalton, IN MY OPINION, used the shares to buy the 51% of BioRemedies. In the past, I have privately said Dalton probably helped "seed" BioRem when they started and probably already owned at least 10% of the company. If so, he probably had an "option to purchase" more of the company in the future for a "price".

Now, it gets real interesting, bear with me here. IMO, Dalton gave the 100 million shares for the 51%. Now lets parse that. First lets value his stock. Doc has said Nasdaq, he wants back on the Nasdaq. The minimum price to get Level One Nasdaq is $2 a share. If you think for one minute Dalton doesn't believe his stock is worth $2 a share, well... So IMO Doc gave them 200 million dollars worth of stock for 51% of their company. But, look at their website, I doubt they are worth a fraction of 400 million dollars (100% value) ON THE SURFACE. Remember FDA products can be developed in secrecy. Now, some will say UNVC is valued at a penny a share, average over 180 days. If BioRem was only worth that valuation then Doc simply would have written them a check for a million dollars and kept his stock! Under that scenario I could care less if he bought 51% of them. So IMO, I have to put on the table that BioRem MAY be sitting on FDA approved cannabis remedies. So, you ask, why have we not merged and launched? Good question. My understanding, if the products contain more than .03% of THC then they can not use the banking system (insurance, etc). Also, IMO you don't "change the pharmaceutical industry" with just another cannabis product. So, is Dalton waiting on the Safe Banking Act to pass Congress so the banking system can be used? Has he wanted to launch in the past year or two but this is so big and other issues he decided to wait? BEFORE you jump on me, we "don't know what we don't know" and this is a multi faceted conglomerate that Doc is building, privately, in a new sector, not an easy task. I trust his business experience and IMO, he has one chance to do this right. IMO, he has now finished developing his companies and, August 21st he said "Lets Get Moving". So, IMO he is ready and is now waiting on someone else.

If I am correct, about the 100M shares, this could be huge. Also it could spell he is close to a launch.

Sorry, I know this was long, but I hope it makes you think about what you MAYBE own.